Saturday, 21 December 2024
Trending

Investing

Constellation Brands target cut by Truist amid sales revision By Investing.com

An investigator-initiated trial (IIT) with Hyundai Bioscience's Xafty by UCSD By Investing.com


Truist Securities revised its outlook on Constellation Brands (NYSE:), reducing the stock’s price target from $265.00 to $255.00 while maintaining a Hold rating. The adjustment follows a reevaluation of the company’s future sales and adjusted earnings per share (EPS) estimates.

The firm now expects Constellation Brands to achieve sales of $10.445 billion and an adjusted EPS of $13.70 for fiscal year 2025, a decrease from the previous estimates of $10.569 billion and $13.72, respectively. Similarly, the fiscal year 2026 sales and adjusted EPS forecasts have been lowered to $10.969 billion and $14.86 from the earlier projections of $11.098 billion and $15.06.

The decision to revise the price target and financial forecasts comes after Constellation Brands’ management presented a reduced sales guidance for both of its reporting segments at an investor conference in September. The updated figures and guidance from the company were more subdued than Truist Securities initially anticipated.

Truist Securities expressed skepticism regarding the reasons provided by Constellation Brands’ management for the slowdown in the beer segment, particularly attributing it to economic factors and unemployment in five key states. The firm remains cautious about the segment’s ability to recover in the second half of the fiscal year.

In summary, Truist Securities has reiterated its Hold rating on Constellation Brands and has adjusted the price target to $255, reflecting a more conservative stance on the company’s financial performance in the upcoming fiscal years.

In other recent news, Constellation Brands, a leading beverage company, is experiencing significant developments in its financial performance. The company’s Q2 Fiscal Year 2025 results highlighted robust growth in its beer segment, with a near 6% increase in net sales and a 13% growth in operating income. However, the wine and spirits segment saw a decrease in shipments and net sales.

Analysts from Roth/MKM, Evercore ISI, and Goldman Sachs maintain a positive outlook on Constellation Brands, reiterating their Buy or Outperform ratings. Despite potential short-term headwinds, these firms express confidence in the company’s growth, particularly in the beer division.

Roth/MKM foresees strong beer shipments driving Constellation Brands toward its FY25 guidance, while Goldman Sachs views the company as a top growth story despite macro pressures. Evercore ISI has adjusted its financial outlook, lowering its price target…

Click Here to Read the Full Original Article at All News…